Evidence map›Paper›PMID 30261611›Full record

ArticleInternational journal of molecular sciences2018

The Tissue-Engineered Human Psoriatic Skin Substitute: A Valuable In Vitro Model to Identify Genes with Altered Expression in Lesional Psoriasis.

Geneviève Rioux, Claudia Pouliot-Bérubé, Mélissa Simard, Manel Benhassine, Jacques Soucy, Sylvain L Guérin, Roxane Pouliot

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. LRG1: an emerging player in disease pathogenesis.Journal of biomedical science · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Geneviève RiouxCentre LOEX de l'Université Laval, Génie Tissulaire et Régénération, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1J 1Z4, Canada. genevieve.rioux.9@ulaval.ca.
Claudia Pouliot-BérubéCentre LOEX de l'Université Laval, Génie Tissulaire et Régénération, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1J 1Z4, Canada. claudia.pouliot-berube.1@ulaval.ca.
Mélissa SimardCentre LOEX de l'Université Laval, Génie Tissulaire et Régénération, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1J 1Z4, Canada. melissa.simard.6@ulaval.ca.
Manel BenhassineCentre Universitaire d'Ophtalmologie-Recherche, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1S4L8, Canada. manal.benhassine.1@ulaval.ca.
Jacques SoucyDépartement de Dermatologie, Hôpital de l'Enfant-Jésus, Québec, QC G1J 1Z4, Canada. jacques.soucy@fmed.ulaval.ca.
Sylvain L GuérinCentre Universitaire d'Ophtalmologie-Recherche, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1S4L8, Canada. sylvain.guerin@fmed.ulaval.ca.
Roxane PouliotCentre LOEX de l'Université Laval, Génie Tissulaire et Régénération, Centre de Recherche FRQS du CHU de Québec, Axe Médecine Régénératrice, Québec, QC G1J 1Z4, Canada. roxane.pouliot@pha.ulaval.ca.
Université Laval · CACentre hospitalier universitaire de Québec · CAHôpital de l'Enfant-Jésus · CA

Funding

Canadian Institutes of Health Research 311262
6 · The paper itself

Abstract

Psoriasis is a chronic inflammatory skin disease for which no cure has emerged. Its complex etiology requires the development of an in vitro model representative of the pathology. In this study, we exploited gene profiling analyses on microarray in order to characterize and further optimize the production of a human psoriatic skin model representative of this in vivo skin disease. Various skin substitutes were produced by tissue-engineering using biopsies from normal, healthy donors, or from lesional or non-lesional skin samples from patients with psoriasis, and their gene expression profiles were examined by DNA microarray. We demonstrated that more than 3540 and 1088 genes (two-fold change) were deregulated between healthy/lesional and lesional/non-lesional psoriatic substitutes, respectively. Moreover, several genes related to lipid metabolism, such as

Indexed as

Skin, ArtificialAdolescentAdultAgedCells, CulturedCytokinesGene Expression ProfilingGene OntologyHumansIntercellular Signaling Peptides and ProteinsMiddle AgedPsoriasisSkinTissue EngineeringYoung AdultCytokinesIntercellular Signaling Peptides and Proteinsgene profilingpsoriasistissue-engineering

Identifiers

PMID30261611
PMCPMC6213003
OpenAlexW2894075989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.